Health & Fitness
Health and Fitness
Health and Fitness
Wed, January 7, 2009
Tue, January 6, 2009 XenoPort to Present at the 27th Annual J.P. Morgan Healthcare Conference
SANTA CLARA, Calif.--([ BUSINESS WIRE ])--XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 27th Annual J.P. Morgan Healthcare Conference. The live presentation will occur at 2:30 p.m. Pacific Time (5:30 p.m. Eastern Time) on Wednesday, January 14, 2009. A replay of the presentation will also be available.
To access the live presentation via the Web, please go to [ www.XenoPort.com ] or to [ https://events.jpmorgan.com ]. The XenoPort presentation can be accessed through the "Conference Webcasts" link for the 27th Annual J.P. Morgan Healthcare Conference. Please connect to the Web site at least 15 minutes prior to the live presentation to ensure adequate time for any software downloads that may be necessary to listen to the Webcast.
A replay of the Webcast can be accessed for a minimum of one month and will be available approximately 24 hours after the live presentation.
About XenoPort
XenoPort, Inc. is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transport mechanisms to improve the therapeutic benefits of existing drugs. XenoPort is developing its lead product candidate in partnership with Astellas Pharma Inc. and GlaxoSmithKline. XenoPort's product candidates are being studied for the potential treatment of restless legs syndrome, neuropathic pain, migraine headaches, gastroesophageal reflux disease, spasticity related to spinal chord injury, acute back spasms and Parkinson's disease.
To learn more about XenoPort, please visit the Web site at [ www.XenoPort.com ].
XenoPort is a registered trademark.
XNPT2G
